An interventional study of VR-Based Mindfulness Intervention in Anxiety, Pain and Varicose Veins of Lower Limb, sponsored by Tongji Hospital. Not yet recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-02.
Sponsored by Tongji Hospital · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 247 studies in Pain with a site in China — 66 open to participants now, 72 under way, 2 of them phase 3. Pain · China.
Among the 247 studies in Pain with a site in China, this one is the 83rd largest by planned enrollment of the 212 interventional ones that give a count, is one of 25 that started in 2026, is one of 117 with no phase, reaches primary completion later than 39 of the 71 other live ones, and was the 207th registered.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
Browse Pain studies →66 of the 247 studies in Pain with a site in China are open now. Recruiting first, the newest first:
Yi Duan · Sites in China
Ages 18–75
Novartis Pharmaceuticals · Sites in China
Ages 18+
Yingyong Zhou,MD,PhD · Sites in China
Ages 18+
Haisco Pharmaceutical Group Co., Ltd. · Sites in China
Ages 18+
Lijiang Lv · Sites in China
Ages 18–60
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
247 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 21 · Phase 2 27 · Phase 3 26 · Phase 4 30
First in 1992; this study’s year is marked. 25 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 160 is above the median of 66 across 8,512 interventional studies indexed under Pain.
Median enrollment 120 across the 212 interventional studies, 169 across the 34 observational. Of the 122 that completed or were terminated, 17 (14%) have results posted.
This tab as a report to print or save as PDF → With an account.
50 of 247 have an industry lead sponsor. The 10 most frequent:
Tongji Hospital is the lead sponsor of 392 studies on the registry; 213 are open to participants now.
Tongji Hospital has 2 studies filed under Pain — fewer than ten, so there is no comparison to draw.
30 of the studies in Pain with a site in China that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07872826Phase 3The Third Xiangya Hospital of Central South UniversityA Clinical Trial Evaluating the Efficacy and Safety of Local Infiltration of RF16001 for Injection for Analgesia After Total Hip Arthroplasty in China | 2027-06-30 |
| NCT07533786Haisco Pharmaceutical Group Co., Ltd.A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal Surgery | 2026-11-22 |
| NCT06553495Jie ChenA Comparative Analysis of Intertransverse Nerve Block and Paravertebral Nerve Block in Endoscopic Hepatectomy | 2026-11-30 |
| NCT07947511Dove Medical Press LtdOral-Challenge Study: Steady-State High-ORP Water/Gel Relieves AITC- and Capsaicin-Induced Oral Pain in Healthy Volunteers | 2026-12-22 |
| NCT07557823Second Affiliated Hospital, School of Medicine, Zhejiang UniversityTranscutaneous Auricular Vagus Nerve Stimulation Combined With Cervical Epidural Injection for Cervical Radiculopathy | 2026-12-30 |
Add all 30 to your calendar (.ics) → With an account.
Among the 247 studies in Pain with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to learn whether a virtual reality (VR)-based mindfulness intervention can reduce anxiety and pain in adults undergoing minimally invasive surgery for lower-extremity varicose veins under local anesthesia. The study will also examine whether the intervention affects vital signs, fatigue, sleep quality, and patient satisfaction.
The main questions this study aims to answer are:
Participants in the VR-based mindfulness group will:
Participants in the control group will receive routine psychological care before and during surgery.
Participants in both groups will:
This is a single-center, prospective, open-label, parallel-group randomized controlled trial involving 160 adults undergoing elective minimally invasive surgery for lower-extremity varicose veins under local anesthesia. After eligibility is confirmed and written informed consent is obtained, participants will complete baseline assessments before being randomly assigned in a 1:1 ratio to the VR-based mindfulness intervention group or the control group. The randomization sequence will be generated using SAS version 9.4, and allocation concealment will be maintained using sequentially numbered, opaque, sealed envelopes.Participants in the intervention group will receive VR-based mindfulness sessions in the preoperative waiting area and during surgery, while participants in the control group will receive routine psychological care. The intraoperative VR-based mindfulness intervention will be repeated till the end of surgery.
State anxiety will be assessed at four time points: approximately 30 minutes before surgery (T0), before the start of surgery (T1), following the first completion of intraoperative VR-based mindfulness session (T2), and at the end of surgery (T3). Participants in the control group will undergo the T2 assessment at the corresponding intraoperative time point.Additional outcomes include pain intensity, blood pressure, heart rate, fatigue, sleep quality, patient satisfaction, and duration of surgery.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
This study's planned enrollment of 160 is above the median of 66 across 8,512 interventional studies indexed under Pain.
Browse Pain studies →Tongji Hospital is the lead sponsor of 392 studies on the registry; 213 are open to participants now.
Compared within Pain, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Anxiety Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →
The criteria were revised on the registry on Nov 2, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in the intervention group will receive routine psychological care plus a VR-based mindfulness intervention.In a separate room within the preoperative waiting area, a trained nurse will assist participants in using Huawei VR Glass to receive prerecorded mindfulness education and guided mindfulness practice. After entering the operating room, participants will receive an intraoperative VR-based mindfulness intervention using prerecorded guided mindfulness content, beginning at the start of surgery. Following the completion of the first intraoperative VR-based mindfulness session and the corresponding anxiety assessment, the intervention will be resumed and may be repeated till the end of surgery.
Behavioral: VR-Based Mindfulness Intervention
Participants in the control group will receive routine psychological care before and during surgery. This will include a preoperative visit to provide information about the surgical procedure, and relevant perioperative considerations, as well as psychological support through reassurance, encouragement, and communication to address patients' concerns.
The VR-based mindfulness intervention will be delivered in two stages on the day of surgery. Before surgery, participants in the intervention group will be transferred to a separate room within the preoperative waiting area, where a mindfulness-trained nurse will assist them in using Huawei VR Glass to receive prerecorded mindfulness education and guided mindfulness practice. At the start of surgery, participants will receive an intraoperative VR-based mindfulness intervention using prerecorded guided mindfulness content, assisted by a trained nurse. Following the completion of the first intraoperative VR-based mindfulness session and the corresponding anxiety assessment, the intervention will be resumed and may be repeated according to the duration of surgery until the end of surgery.
State-Trait Anxiety Inventory-State Subscale (STAI-State)
The STAI-State is a 20-item self-report measure of state anxiety. Each item is rated on a 4-point scale, yielding a total score ranging from 20 to 80. Higher scores indicate greater levels of state anxiety.
Time frame: Approximately 30 minutes before surgery (T0), immediately before surgery (T1), following completion of the first intraoperative VR-based mindfulness session (T2), and at the end of surgery (T3). The control group will be assessed at the same time.
Pain Intensity (Numeric Rating Scale, NRS)
Pain intensity will be assessed using the Numeric Rating Scale (NRS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain imaginable. At the end of surgery, participants will report both their highest pain experienced during surgery and their current pain intensity.
Time frame: Approximately 30 min before surgery and at surgery end, when maximum intraoperative pain and current pain intensity will be assessed.
blood pressure
Systolic and diastolic blood pressure will be measured in mmHg using the perioperative patient monitor.
Time frame: Approximately 30 min before surgery, immediately before surgery, and every 5 min from the start of surgery until the end of surgery.
Fatigue (Brief Fatigue Inventory, BFI)
Fatigue will be assessed using the 9-item Brief Fatigue Inventory (BFI). Each item is rated on an 11-point scale ranging from 0 to 10, with higher scores indicating greater fatigue severity or interference. The overall BFI score will be calculated as the mean of the nine item scores, ranging from 0 to 10.
Time frame: Upon arrival in the preoperative waiting area (baseline) and on postoperative day 1.
Sleep Quality (Leeds Sleep Evaluation Questionnaire, LSEQ)
Sleep quality will be assessed using the 10-item Leeds Sleep Evaluation Questionnaire (LSEQ), covering four domains: getting to sleep, quality of sleep, awakening, and post-awakening behavior. Each item is rated on a 100-mm visual analogue scale.
Time frame: Upon arrival in the preoperative waiting area (baseline) and on postoperative day 1.
Satisfaction scale
Each dimension is scored using a 5-point Likert scale ranging from " never" (1 point) to "very frequently or always" (5 points).Higher scores indicate greater patient satisfaction
Time frame: 24 hours postoperatively (Day 1)
heart rate
Heart rate will be measured in beats per minute (bpm) using the perioperative patient monitor. Intraoperative values will be monitored every 5 minutes and automatically recorded by the monitoring system.
Time frame: Approximately 30 min before surgery, immediately before surgery, and every 5 min from the start of surgery until the end of surgery.
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Start is estimated for Nov 2026; primary completion for Jun 2027, 7 months later.
Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 7 months is below that.
Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.
Start moved twice since we started tracking on Sep 25, 2026: Jul 2026 → Nov 2026, last on Nov 2, 2026.
Primary completion moved once since we started tracking on Sep 25, 2026: Jan 2027 → Jun 2027, on Oct 7, 2026.
Completion moved once since we started tracking on Sep 25, 2026: Jan 2027 → Jul 2027, on Oct 7, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.